[Preventive therapy of central nervous system leukemia in children. II. Results of CNS-prophylaxis with 2,400 rads of cranial irradiation and intrathecal injection of methotrexate and hydrocortisone (author's transl)]. 1977

J Fujimoto, and N Goya, and Y Hiyoshi, and T Yokoyama, and K Hasegawa, and M Ito, and K Nose, and S Anan, and P Y Kim, and M Furusho, and K Jingu, and K Matsuura, and Y Ono, and H Oobtake, and A Ashizawa, and K Hirakawa, and S Kurauchi, and K Kawahira, and J Matsuoka

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007278 Injections, Spinal Introduction of therapeutic agents into the spinal region using a needle and syringe. Injections, Intraspinal,Injections, Intrathecal,Intraspinal Injections,Intrathecal Injections,Spinal Injections,Injection, Intraspinal,Injection, Intrathecal,Injection, Spinal,Intraspinal Injection,Intrathecal Injection,Spinal Injection
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008577 Meningeal Neoplasms Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord. Intracranial Meningeal Neoplasms,Spinal Meningeal Neoplasms,Benign Meningeal Neoplasms,Leptomeningeal Neoplasms,Malignant Meningeal Neoplasms,Meningeal Cancer,Meningeal Neoplasms, Benign,Meningeal Neoplasms, Intracranial,Meningeal Neoplasms, Malignant,Meningeal Tumors,Neoplasms, Leptomeningeal,Neoplasms, Meningeal,Benign Meningeal Neoplasm,Cancer, Meningeal,Cancers, Meningeal,Intracranial Meningeal Neoplasm,Leptomeningeal Neoplasm,Malignant Meningeal Neoplasm,Meningeal Cancers,Meningeal Neoplasm,Meningeal Neoplasm, Benign,Meningeal Neoplasm, Intracranial,Meningeal Neoplasm, Malignant,Meningeal Neoplasm, Spinal,Meningeal Neoplasms, Spinal,Meningeal Tumor,Neoplasm, Benign Meningeal,Neoplasm, Intracranial Meningeal,Neoplasm, Leptomeningeal,Neoplasm, Malignant Meningeal,Neoplasm, Meningeal,Neoplasm, Spinal Meningeal,Neoplasms, Benign Meningeal,Neoplasms, Intracranial Meningeal,Neoplasms, Malignant Meningeal,Neoplasms, Spinal Meningeal,Spinal Meningeal Neoplasm,Tumor, Meningeal,Tumors, Meningeal
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol

Related Publications

J Fujimoto, and N Goya, and Y Hiyoshi, and T Yokoyama, and K Hasegawa, and M Ito, and K Nose, and S Anan, and P Y Kim, and M Furusho, and K Jingu, and K Matsuura, and Y Ono, and H Oobtake, and A Ashizawa, and K Hirakawa, and S Kurauchi, and K Kawahira, and J Matsuoka
February 1977, [Rinsho ketsueki] The Japanese journal of clinical hematology,
J Fujimoto, and N Goya, and Y Hiyoshi, and T Yokoyama, and K Hasegawa, and M Ito, and K Nose, and S Anan, and P Y Kim, and M Furusho, and K Jingu, and K Matsuura, and Y Ono, and H Oobtake, and A Ashizawa, and K Hirakawa, and S Kurauchi, and K Kawahira, and J Matsuoka
June 1979, [Rinsho ketsueki] The Japanese journal of clinical hematology,
J Fujimoto, and N Goya, and Y Hiyoshi, and T Yokoyama, and K Hasegawa, and M Ito, and K Nose, and S Anan, and P Y Kim, and M Furusho, and K Jingu, and K Matsuura, and Y Ono, and H Oobtake, and A Ashizawa, and K Hirakawa, and S Kurauchi, and K Kawahira, and J Matsuoka
December 1977, Nihon Gan Chiryo Gakkai shi,
J Fujimoto, and N Goya, and Y Hiyoshi, and T Yokoyama, and K Hasegawa, and M Ito, and K Nose, and S Anan, and P Y Kim, and M Furusho, and K Jingu, and K Matsuura, and Y Ono, and H Oobtake, and A Ashizawa, and K Hirakawa, and S Kurauchi, and K Kawahira, and J Matsuoka
January 1965, Blood,
J Fujimoto, and N Goya, and Y Hiyoshi, and T Yokoyama, and K Hasegawa, and M Ito, and K Nose, and S Anan, and P Y Kim, and M Furusho, and K Jingu, and K Matsuura, and Y Ono, and H Oobtake, and A Ashizawa, and K Hirakawa, and S Kurauchi, and K Kawahira, and J Matsuoka
December 1974, Strahlentherapie,
J Fujimoto, and N Goya, and Y Hiyoshi, and T Yokoyama, and K Hasegawa, and M Ito, and K Nose, and S Anan, and P Y Kim, and M Furusho, and K Jingu, and K Matsuura, and Y Ono, and H Oobtake, and A Ashizawa, and K Hirakawa, and S Kurauchi, and K Kawahira, and J Matsuoka
August 1983, Blood,
J Fujimoto, and N Goya, and Y Hiyoshi, and T Yokoyama, and K Hasegawa, and M Ito, and K Nose, and S Anan, and P Y Kim, and M Furusho, and K Jingu, and K Matsuura, and Y Ono, and H Oobtake, and A Ashizawa, and K Hirakawa, and S Kurauchi, and K Kawahira, and J Matsuoka
March 2008, Pediatric blood & cancer,
J Fujimoto, and N Goya, and Y Hiyoshi, and T Yokoyama, and K Hasegawa, and M Ito, and K Nose, and S Anan, and P Y Kim, and M Furusho, and K Jingu, and K Matsuura, and Y Ono, and H Oobtake, and A Ashizawa, and K Hirakawa, and S Kurauchi, and K Kawahira, and J Matsuoka
January 1983, Sangre,
J Fujimoto, and N Goya, and Y Hiyoshi, and T Yokoyama, and K Hasegawa, and M Ito, and K Nose, and S Anan, and P Y Kim, and M Furusho, and K Jingu, and K Matsuura, and Y Ono, and H Oobtake, and A Ashizawa, and K Hirakawa, and S Kurauchi, and K Kawahira, and J Matsuoka
September 1976, Hiroshima journal of medical sciences,
J Fujimoto, and N Goya, and Y Hiyoshi, and T Yokoyama, and K Hasegawa, and M Ito, and K Nose, and S Anan, and P Y Kim, and M Furusho, and K Jingu, and K Matsuura, and Y Ono, and H Oobtake, and A Ashizawa, and K Hirakawa, and S Kurauchi, and K Kawahira, and J Matsuoka
February 1983, Blood,
Copied contents to your clipboard!